✉  info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Ophthalmic Drugs Market Research Report Information by Dosage Form (Eye Drops, Eye Ointments, Eye Solutions, Gels, Capsules & Tablets and others), Product Type (Prescription Drug and OTC Drug), Drug Class (Antibiotics, Anti-Inflammatory, Anti-Glaucoma and others), Indication (Glaucoma, Retinal Disorder, Dry Eye, Eye Allergy and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2034


ID: MRFR/Pharma/4298-HCR | 95 Pages | Author: Rahul Gotadki| April 2025

Market Segmentation

Ophthalmic Drugs Dosage Form Outlook (USD Billion, 2019-2030)




  • Eye Drops




  • Eye Ointments




  • Eye Solutions




  • Gels




  • Capsules & Tablets




  • Others




Ophthalmic Drugs Product Type Outlook (USD Billion, 2019-2030)




  • Prescription Drug




  • OTC Drug




Ophthalmic Drugs Drug Class Outlook (USD Billion, 2019-2030)




  • Antibiotics




  • Anti-Inflammatory




  • Anti-Glaucoma




  • Others




Ophthalmic Drugs Indication Outlook (USD Billion, 2019-2030)




  • Glaucoma




  • Retinal Disorder




  • Dry Eye




  • Eye Allergy




  • Others




Ophthalmic Drugs Distribution Channels Outlook (USD Billion, 2019-2030)




  • Hospital pharmacies




  • Drug stores




  • Online pharmacies




  • Others




Ophthalmic Drugs Regional Outlook (USD Billion, 2019-2030)




  • North America Outlook (USD Billion, 2019-2030)




    • North America Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • North America Ophthalmic Drugs by Product Type




      • Prescription Drug




      • OTC Drug






    • North America Ophthalmic Drugs by Drug Class




      • Antibiotics




      • Anti-Inflammatory




      • Anti-Glaucoma




      • Others






    • North America Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • North America Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • US Outlook (USD Billion, 2019-2030)




    • US Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • US Ophthalmic Drugs by Product Type




      • Prescription Drug




      • OTC Drug






    • US Ophthalmic Drugs by Drug Class




      • Antibiotics




      • Anti-Inflammatory




      • Anti-Glaucoma




      • Others






    • US Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • US Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • CANADA Outlook (USD Billion, 2019-2030)




    • CANADA Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • CANADA Ophthalmic Drugs by Product Type




      • Prescription Drug




      • OTC Drug






    • CANADA Ophthalmic Drugs by Drug Class




      • Antibiotics




      • Anti-Inflammatory




      • Anti-Glaucoma




      • Others






    • CANADA Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • CANADA Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others








  • Europe Outlook (USD Billion, 2019-2030)




    • Europe Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Europe Ophthalmic Drugs by Product Type




      • Prescription Drug




      • OTC Drug






    • Europe Ophthalmic Drugs by Drug Class




      • Antibiotics




      • Anti-Inflammatory




      • Anti-Glaucoma




      • Others






    • Europe Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Europe Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • Germany Outlook (USD Billion, 2019-2030)




    • Germany Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Germany Ophthalmic Drugs by Product Type




      • Prescription Drug




      • OTC Drug






    • Germany Ophthalmic Drugs by Drug Class




      • Antibiotics




      • Anti-Inflammatory




      • Anti-Glaucoma




      • Others






    • Germany Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Germany Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • France Outlook (USD Billion, 2019-2030)




    • France Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • France Ophthalmic Drugs by Product Type




      • Prescription Drug




      • OTC Drug






    • France Ophthalmic Drugs by Drug Class




      • Antibiotics




      • Anti-Inflammatory




      • Anti-Glaucoma




      • Others






    • France Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • France Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • UK Outlook (USD Billion, 2019-2030)




    • UK Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • UK Ophthalmic Drugs by Product Type




      • Prescription Drug




      • OTC Drug






    • UK Ophthalmic Drugs by Drug Class




      • Antibiotics




      • Anti-Inflammatory




      • Anti-Glaucoma




      • Others






    • UK Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • UK Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • ITALY Outlook (USD Billion, 2019-2030)




    • ITALY Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • ITALY Ophthalmic Drugs by Product Type




      • Prescription Drug




      • OTC Drug






    • ITALY Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • ITALY Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • ITALY Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others

















    • SPAIN Outlook (USD Billion, 2019-2030)




    • Spain Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Spain Ophthalmic Drugs by Product Type




      • Prescription Drug




      • OTC Drug






    • Spain Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • Spain Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Spain Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • Rest Of Europe Outlook (USD Billion, 2019-2030)




    • Rest Of Europe Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • REST OF EUROPE Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • REST OF EUROPE Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • REST OF EUROPE Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • REST OF EUROPE Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others







  • Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Asia-Pacific Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Asia-Pacific Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • Asia-Pacific Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • Asia-Pacific Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Asia-Pacific Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • China Outlook (USD Billion, 2019-2030)




    • China Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • China Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • China Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • China Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • China Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • Japan Outlook (USD Billion, 2019-2030)




    • Japan Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Japan Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • Japan Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • Japan Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Japan Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • India Outlook (USD Billion, 2019-2030)




    • India Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • India Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • India Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • India Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • India Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • Australia Outlook (USD Billion, 2019-2030)




    • Australia Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Australia Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • Australia Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • Australia Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Australia Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Rest of Asia-Pacific Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Rest of Asia-Pacific Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • Rest of Asia-Pacific Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • Rest of Asia-Pacific Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Rest of Asia-Pacific Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others








  • Rest of the World Outlook (USD Billion, 2019-2030)




    • Rest of the World Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Rest of the World Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • Rest of the World Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • Rest of the World Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Rest of the World Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others














    • Middle East Outlook (USD Billion, 2019-2030)




    • Middle East Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Middle East Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • Middle East Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • Middle East Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Middle East Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • Africa Outlook (USD Billion, 2019-2030)




    • Africa Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Africa Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • Africa Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • Africa Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Africa Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






    • Latin America Outlook (USD Billion, 2019-2030)




    • Latin America Ophthalmic Drugs by Dosage Form




      • Eye Drops




      • Eye Ointments




      • Eye Solutions




      • Gels




      • Capsules & Tablets




      • Others






    • Latin America Ophthalmic Drugs byProduct Type




      • Prescription Drug




      • OTC Drug






    • Latin America Ophthalmic Drugs by Drug Class




      • Antisense & RNAi Therapy




      • Gene Therapy




      • Cell Therapy




      • Vaccinology




      • Research






    • Latin America Ophthalmic Drugs by Indication




      • Glaucoma




      • Retinal Disorder




      • Dry Eye




      • Eye Allergy




      • Others






    • Latin America Ophthalmic Drugs by Distribution Channels




      • Hospital pharmacies




      • Drug stores




      • Online pharmacies




      • Others






Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM

6.1. Overview

6.2. Eye Drops

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Eye Ointments

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4. Eye Solutions

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5. Eye Gels

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.6. Eye Capsules & Tablets

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.7. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7. GLOBAL OPHTHALMIC DRUGS MARKET, BY DRUG CLASS

7.1. Overview

7.2. Antibiotics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. Nonsteroidal Drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4. Anti-allergy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5. Anti-Inflammatory

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6. Anti-Glaucoma

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.7. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8. GLOBAL OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE

8.1. Overview

8.2. Prescription Drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3. OTC Drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9. GLOBAL OPHTHALMIC DRUGS MARKET, BY INDICATION

9.1. Overview

9.2. Allergy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.3. Dry Eye

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.4. Glaucoma

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.5. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

10. GLOBAL OPHTHALMIC DRUGS MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1.1. Overview

11.1.2. Competitive Analysis

12. COMPANY PROFILE

12.1. Novartis AG

12.1.1. Overview

12.1.2. Product Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Allergan Plc

12.2.1. Overview

12.2.2. Product Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. F. Hoffmann-La Roche AG

12.3.1. Overview

12.3.2. Product Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Bausch Health Companies Inc

12.4.1. Overview

12.4.2. Product Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Pfizer Inc.

12.5.1. Overview

12.5.2. Product Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Bayer AG

12.6.1. Overview

12.6.2. Product Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Merck & Co., Inc.

12.7.1. Overview

12.7.2. Product Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Regeneron Pharmaceuticals, Inc.

12.8.1. Overview

12.8.2. Product Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Aerie Pharmaceuticals, Inc.

12.9.1. Overview

12.9.2. Product Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Santen Pharmaceutical Co., Ltd

12.10.1. Overview

12.10.2. Product Overview

12.10.3. Financial Overview

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Others

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL OPHTHALMIC DRUGS MARKET SYNOPSIS, 2020–2027

TABLE 2 GLOBAL OPHTHALMIC DRUGS MARKET ESTIMATES AND FORECAST, 2020–2027 (USD MILLION)

TABLE 3 GLOBAL OPHTHALMIC DRUGS MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 4 GLOBAL OPHTHALMIC DRUGS MARKET, BY FORM, 2020–2027 (USD MILLION)

TABLE 5 GLOBAL OPHTHALMIC DRUGS MARKET, BY INDICATION, 2020–2027 (USD MILLION)

TABLE 6 GLOBAL OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 7 GLOBAL OPHTHALMIC DRUGS MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: OPHTHALMIC DRUGS MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, 2020–2027 (USD MILLION)

TABLE 10 NORTH AMERICA: OPHTHALMIC DRUGS MARKET, BY INDICATION, 2020–2027 (USD MILLION)

TABLE 11 NORTH AMERICA: OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 12 US: OPHTHALMIC DRUGS MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 13 US: OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, 2020–2027 (USD MILLION)

TABLE 14 US: OPHTHALMIC DRUGS MARKET, BY INDICATION, 2020–2027 (USD MILLION)

TABLE 15 US: OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 16 CANADA: OPHTHALMIC DRUGS MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 17 CANADA: OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, 2020–2027 (USD MILLION)

TABLE 18 CANADA: OPHTHALMIC DRUGS MARKET, BY INDICATION, 2020–2027 (USD MILLION)

TABLE 19 CANADA: OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 20 LATIN AMERICA: OPHTHALMIC DRUGS MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 21 LATIN AMERICA: OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, 2020–2027 (USD MILLION)

TABLE 22 LATIN AMERICA: OPHTHALMIC DRUGS MARKET, BY INDICATION, 2020–2027 (USD MILLION)

TABLE 23 LATIN AMERICA: OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 24 EUROPE: OPHTHALMIC DRUGS MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 25 EUROPE: OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, 2020–2027 (USD MILLION)

TABLE 26 EUROPE: OPHTHALMIC DRUGS MARKET, BY INDICATION, 2020–2027 (USD MILLION)

TABLE 27 EUROPE: OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 28 WESTERN EUROPE: OPHTHALMIC DRUGS MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 29 WESTERN EUROPE: OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, 2020–2027 (USD MILLION)

TABLE 30 WESTERN EUROPE: OPHTHALMIC DRUGS MARKET, BY INDICATION, 2020–2027 (USD MILLION)

TABLE 31 WESTERN EUROPE: OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 32 EASTERN EUROPE: OPHTHALMIC DRUGS MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 33 EASTERN EUROPE: OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, 2020–2027 (USD MILLION)

TABLE 34 EASTERN EUROPE: OPHTHALMIC DRUGS MARKET, BY INDICATION, 2020–2027 (USD MILLION)

TABLE 35 EASTERN EUROPE: OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC: OPHTHALMIC DRUGS MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC: OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, 2020–2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC: OPHTHALMIC DRUGS MARKET, BY INDICATION, 2020–2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC: OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: OPHTHALMIC DRUGS MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, 2020–2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: OPHTHALMIC DRUGS MARKET, BY INDICATION, 2020–2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: OPHTHALMIC DRUGS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL OPHTHALMIC DRUGS MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL OPHTHALMIC DRUGS MARKET

FIGURE 4 GLOBAL OPHTHALMIC DRUGS MARKET SHARE, BY DRUG CLASS, 2020 (%)

FIGURE 5 GLOBAL OPHTHALMIC DRUGS MARKET SHARE, BY DOSAGE FORM, 2020 (%)

FIGURE 6 GLOBAL OPHTHALMIC DRUGS MARKET SHARE, BY INDICATION, 2020 (%)

FIGURE 7 GLOBAL OPHTHALMIC DRUGS MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 NORTH AMERICA: OPHTHALMIC DRUGS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 9 EUROPE: OPHTHALMIC DRUGS MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 WESTERN EUROPE: OPHTHALMIC DRUGS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 ASIA-PACIFIC: OPHTHALMIC DRUGS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 MIDDLE EAST & AFRICA: OPHTHALMIC DRUGS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 GLOBAL OPHTHALMIC DRUGS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 14 NOVARTIS AG: KEY FINANCIALS

FIGURE 15 NOVARTIS AG: SEGMENTAL REVENUE

FIGURE 16 NOVARTIS AG: REGIONAL REVENUE

FIGURE 17 ALLERGAN PLC: KEY FINANCIALS

FIGURE 18 ALLERGAN PLC: SEGMENTAL REVENUE

FIGURE 19 ALLERGAN PLC: REGIONAL REVENUE

FIGURE 20 F. HOFFMANN-LA ROCHE AG: KEY FINANCIALS

FIGURE 21 F. HOFFMANN-LA ROCHE AG: SEGMENTAL REVENUE

FIGURE 22 F. HOFFMANN-LA ROCHE AG: REGIONAL REVENUE

FIGURE 23 BAUSCH HEALTH COMPANIES INC: KEY FINANCIALS

FIGURE 24 BAUSCH HEALTH COMPANIES INC: SEGMENTAL REVENUE

FIGURE 25 BAUSCH HEALTH COMPANIES INC: REGIONAL REVENUE

FIGURE 26 PFIZER INC: KEY FINANCIALS

FIGURE 27 PFIZER INC: SEGMENTAL REVENUE

FIGURE 28 PFIZER INC: REGIONAL REVENUE

FIGURE 29 BAYER AG: KEY FINANCIALS

FIGURE 30 BAYER AG: SEGMENTAL REVENUE

FIGURE 31 BAYER AG: REGIONAL REVENUE

FIGURE 32 MERCK & CO., INC.: KEY FINANCIALS

FIGURE 33 MERCK & CO., INC.: SEGMENTAL REVENUE

FIGURE 34 MERCK & CO., INC.: REGIONAL REVENUE

FIGURE 35 REGENERON PHARMACEUTICALS, INC.: KEY FINANCIALS

FIGURE 36 REGENERON PHARMACEUTICALS, INC.: SEGMENTAL REVENUE

FIGURE 37 REGENERON PHARMACEUTICALS, INC.: REGIONAL REVENUE

FIGURE 38 AERIE PHARMACEUTICALS, INC.: KEY FINANCIALS

FIGURE 39 AERIE PHARMACEUTICALS, INC.: SEGMENTAL REVENUE

FIGURE 40 AERIE PHARMACEUTICALS, INC.: REGIONAL REVENUE

FIGURE 41 SANTEN PHARMACEUTICAL CO., LTD: KEY FINANCIALS

FIGURE 42 SANTEN PHARMACEUTICAL CO., LTD: SEGMENTAL REVENUE

FIGURE 43 SANTEN PHARMACEUTICAL CO., LTD: REGIONAL REVENUE

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
report-img
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
France Ophthalmic Drugs Market Research Report - Forecast to 2035
report-img
US Ophthalmic Drugs Market Research Report- Forecast to 2035
report-img
China Ophthalmic Drugs Market Research Report - Forecast to 2035
report-img
Spain Ophthalmic Drugs Market Research Report-Forecast to 2035
Press Release
pr-img
Ophthalmic Drugs Market is predicted to reach USD 31.46 billion at a CAGR of 7.80% during the for...
Logo
861332069 Dmca
Paypal new Ssl cf new
Services Syndicate Reports Category Intelligence News How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners Paymentoptions
ISO Certifications
Iso new
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)
📞  +91 2269738890(APAC)

© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)